News   News
Search
Contact us
Your position:Home > News > IndustryNews

Shanghai Lu Xiangyi reconciles 8 centrifuges for large pharmaceutical companies for vaccine development

2018/11/2 9:21:13      click :

       Shanghai Lu Xiangyi reconciles 8 centrifuges for large pharmaceutical companies for vaccine development

  On the 7th of September, the State Food and Drug Administration issued a report on the risk investigation results of 45 existing vaccine manufacturers in the country. The results showed that the existing production enterprises had normal production of vaccine varieties (excluding longevity organisms). No vaccine quality safety issues were found. At the same time, the State Food and Drug Administration said that it will continue to monitor the high-pressure situation of vaccine products, further improve the quality management system, enhance risk control, increase flight inspection and tracking efforts, and regulate the production of the vaccine industry.


   The vaccine has saved the lives of countless people, but at the same time, if there is a problem vaccine, then the lives of countless people may be in danger. It is understood that the cost of vaccine research and development is expensive. After many companies have invested huge amounts of money in the early stage, once they start mass production in the later stage, they may face the temptation of “returning to profit”, which strengthens vaccine supervision and enhances risk control. Improving the technical level and quality of relevant equipment for vaccine development and production is critical to improving the quality of vaccines.


   The author was informed that in order to maintain the conscience and help pharmaceutical companies to balance and choose between profit and social responsibility, and to provide reliable and reliable vaccine products for the domestic market, Shanghai Luxiangyi Centrifuge Instrument Co., Ltd. is working on a new vaccine research and development field. The large-scale drug research and development companies that have established trees supply eight DL-6MS high-capacity refrigerated centrifuges.


DL-6MS large capacity refrigerated centrifuge

  According to reports, the Shanghai Lu Xiangyi service company is not guided by commercial interests, but is scientific research-oriented to motivate scientists, always put patients in the first place, as a pharmaceutical company, it has the courage to undertake social responsibility, for many domestic Pharmaceutical companies have set an example.


  The DL-6M large capacity refrigerated centrifuge developed by Shanghai Lu Xiangyi is specially designed for customers with large capacity requirements. This model has a large amount of sample processing and is an important equipment in the fields of blood station, pharmaceutical and bioengineering.


  The centrifuge has a maximum capacity of 1200mlx6, and the cooling and heating dual-channel temperature control meets the component blood separation temperature; the microcomputer control, the large torque AC variable frequency motor drive, stable operation, low noise and high rotational speed precision. It adopts imported high-performance compressor unit and fluorine-free refrigerant R404a, which meets environmental protection requirements and has good cooling effect; touch panel, programmable operation, host operation parameters can be set and automatically stored according to requirements; large-screen LCD display and digital display supply options, User-friendly interface, easy to operate; real-time rpm/RCF reading conversion and setting, convenient and fast; equipped with electronic door lock, with door cover self-locking, overspeed, over temperature, unbalance and other protection functions, automatic fault The alarm function is safe and reliable; with 10 program's up/down rate curve, the up/down speed can be set as needed; the food grade silicone rubber integral seal is CMP certified, and the centrifuge is FDA certified.


  Shanghai Lu Xiangyi is a professional manufacturer of centrifuges. Since its establishment more than 40 years ago, it has been engaged in the research and development and production of centrifuges. It has always adhered to the quality policy of “Quality First, Credit First” to provide customers with high quality and high quality. Technical content of the product. Through more than 40 years of development, Shanghai Lu Xiangyi has strong technical strength, and its production equipment is excellent, stable performance, novel style, and is well received by the market. This cooperation with related vaccine companies, Shanghai Lu Xiangyi can be a heavy responsibility.


  “After receiving the task, our R&D team constantly communicated with the company to strive to make the equipment more perfect and contribute to the vaccine industry,” the relevant staff said. The quality of vaccines is related to the health of thousands of families. The problem vaccine case is shocking. In order to improve the quality of vaccines and ensure the safety of vaccines, pharmaceutical and equipment companies should always put patients first, and pharmaceutical equipment companies should continue to improve their technical level. Pharmaceutical companies provide strong equipment support and strive to achieve "priority technology solutions that can be solved by technical means."